|
|
|
|
Vol. 62, Issue 4, 765-771, October 2002
Drug Discovery Program, H. Lee Moffitt Cancer Center & Research
Institute (A.K., D.M.S., Q.Z., Q.P.D.), and Departments of
Interdisciplinary Oncology (A.K., Q.Z., Q.P.D.) and Biochemistry & Molecular Biology (D.M.S., Q.P.D.), College of Medicine, University of
South Florida, Tampa, Florida
Prostate cancer cells demonstrate slow growth kinetics and
chemoresistance. Tea polyphenols have been shown to exert prostate cancer-preventative effects. Here we report that growth-arrested prostate cancer cells expressed high levels of a hyperphosphorylated Bcl-XL in mitochondria. Treatment with tea polyphenols or
the major tea component epigallocatechin-3-gallate blocked expression of the hyper-, but not hypophosphorylated Bcl-XL in
mitochondria, accompanied by cytochrome c release,
caspase activation, and apoptosis. Studies using specific inhibitors
suggest that tea inhibits p38 mitogen-activated protein kinase and the
proteasome activities, leading to inhibition of Bcl-XL
phosphorylation and induction of prostate cancer cell death.